|
⚲
|
| Keyboard |
| Head Jonathan Frederick
✚
|
|
|---|---|
| CIK # | 0001653951 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001653951] | |
| 4 | [0001653951] | |
| SC 13D | [0001653951] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Head Jonathan Frederick | Oncbiomune Pharmaceuticals Inc | [2016-02-04] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Theralink Technologies Inc | |
| Head Jonathan Frederick |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Theralink Technologies Inc OBMP
Shares of Common Stock
|
2020-05-07 | Grant | 166,667 | $0.06 | 10,000 |
|
Theralink Technologies Inc OBMP
Option (right to buy) · derivative
|
2018-05-09 | Grant | 3,000,000 | ||
|
Theralink Technologies Inc OBMP
Series B Preferred Stock
|
2017-03-10 | Other | 2,892,000 | ||
|
Theralink Technologies Inc OBMP
Common stock
|
2015-09-02 | Sell | 1,025,000 | $0.00 | |
|
Theralink Technologies Inc OBMP
Common stock
|
2015-09-02 | Grant | 17,951,078 |